Bridge Therapeutics
0 followers
Bridge Therapeutics®, based in Birmingham, Ala., is an innovative development-stage specialty pharmaceutical company pursuing U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) approvals of a patented (U.S. Patent #8410092) drug combination, BT-205, for the treatment of chro... Read more
Org chart
David Bergstrom
Chief Executive Officer
David Bergstrom
Collapse
Alton S. Kelley
Director of Business Development
Tim Peara
President & Finance Director
Greg Sullivan
Chairman & Chief Science Officer
